An incretin-based tri-agonist promotes superior insulin secretion from murine pancreatic islets via PLC activation
Noushafarin Khajavi(Institute of Experimental Endocrinology of the Slovak Academy of Sciences), Heike Biebermann(Humboldt-Universität zu Berlin), Oliver Kluth(Deutsches Diabetes-Zentrum e.V.), Annette Schürmann(University of Potsdam), Brian Finan(Eli Lilly (United States)), Timo D. Müller(Anton Paar (Austria)), Thomas Gudermann(German Center for Lung Research), Patrick Scheerer(Humboldt-Universität zu Berlin), Richard D. DiMarchi(Indiana University Bloomington), Heiko Krude(Humboldt-Universität zu Berlin), Stefan Mergler(Humboldt-Universität zu Berlin), Angela Schulz(Leipzig University), Matthias H. Tschöp(Helmholtz Zentrum München), Gunnar Kleinau(Humboldt-Universität zu Berlin)
Cited by 18
Related Papers
Circulating Ghrelin Levels Are Decreased in Human Obesity
|Diabetes|2001|2k
Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans
|Nature Genetics|1998|1.7k
Anti-obesity drug discovery: advances and challenges
|Nature Reviews Drug Discovery|2021|983
A guide to analysis of mouse energy metabolism
|Nature Methods|2011|816
Dietary Fructose Reduces Circulating Insulin and Leptin, Attenuates Postprandial Suppression of Ghrelin, and Increases Triglycerides in Women
|The Journal of Clinical Endocrinology & Metabolism|2004|747